Mark R. Nicolls MD

Critical Care Medicine, Lung Transplantation Medicine, Pleural Disease, Pulmonary Vascular Medicine

Professor at Stanford/VA Palo Alto Chief, Pulmonary, Allergy & Critical Care Medicine at Stanford Associate Dean of Research

Summary

Dr. Mark Nicolls is a pulmonologist in Palo Alto, CA and is affiliated with multiple hospitals in the area, including Stanford Health Care and VA Palo Alto Health Care System. He received his medical degree from Stanford University School of Medicine and has been in practice 24 years. He specializes in lung transplantation medicine, pleural disease, and pulmonary vascular medicine and is experienced in transplant pulmonology, lung transplantation, critical care medicine, bronchiolitis obliterans, lymphatic disease, and general pulmonology.

University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1996 - 2000
Stanford University School of MedicineClass of 1993

Association of American Physicians 2020
American Society for Clinical Investigation 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011

PubMed

Altered baseline immunological state and impaired immune response to SARS-CoV-2 mRNA vaccination in lung transplant recipients.
Mengyun Hu, Ana Paula B N Oliveira, Zhuoqing Fang, Yupeng Feng, Molly Miranda
Cell Reports. Medicine. 2025-04-01
A Cross-Species and Sex-Specific Meta-Analysis of Transcriptomic Studies of Pulmonary Hypertension.
Lan Zhao, Christine M Cunningham, Jason Hong, Stuti Agarwal, Ke Yuan
American Journal of Respiratory Cell and Molecular Biology. 2025-02-10
1 citations
CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplant.
Husham Sharifi, Christopher D Bertini, Mansour Alkhunaizi, Maria Hernandez, Zayan Musa
Blood Advances. 2024-10-08

Breathing Current Bay Area Air Compares to Smoking '8 Cigarettes,' Health Expert SaysSeptember 15th, 2020
Inflammation Triggers Silent Mutation to Cause Deadly Lung DiseaseAugust 29th, 2019
Anti-Inflammatory Drug Effective for Treating Lymphedema SymptomsOctober 18th, 2018
Join now to see all

BMPR2, Monocytes and Macrophages in Pulmonary Artery HypertensionSTANFORD UNIVERSITY2017–2028
Vaccination responses in lung transplant recipientsSTANFORD UNIVERSITY2022–2027
BMPR2 mutations, Neointimal Transformation and Pulmonary Arterial HypertensionVETERANS ADMIN PALO ALTO HEALTH CARE SYS2021–2026
Stanford Training Program in Lung BiologySTANFORD UNIVERSITY2016–2026
Regulatory T Cells and Pulmonary HypertensionPALO ALTO VETERANS INSTIT FOR RESEARCH2021–2025
Critical Role for Microvasculature in Airway TransplantationPALO ALTO VETERANS INSTIT FOR RESEARCH2010–2025
A Critical Role for Leukotriene B4 in LymphedemaPALO ALTO VETERANS INSTIT FOR RESEARCH2019–2024
The Role Of Complement In Airway Microvascular DiseaseVeterans Affairs2011
Elafin To Prevent Acute Rejection Following Lung TransplantationNational Heart, Lung, And Blood Institute2011
An Autoimmune Basis For Pulmonary Hypertension.National Heart, Lung, And Blood Institute2007–2009
An Autoimmune Basis For Pulmonary Hypertension.National Heart, Lung, And Blood Institute2006
Viability Assay For Human Islet TransplantationNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2005
Mechanisms Of Allograft ToleranceNational Institute Of Diabetes And Digestive And Kidney Diseases2003
Mechanisms Of Allograft ToleranceNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2003